• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

ViCentra

6 diabetes tech companies you need to know

August 7, 2026 By Sean Whooley

Sequel MedTech twiist automated insulin pump with FreeStyle Libre sensor worn on arm

You may already know a lot of the names that are considered leaders of the diabetes technology industry. The likes of Abbott and Dexcom are leaders in the continuous glucose monitor (CGM) space. MiniMed, Insulet and Tandem Diabetes Care are a few of the companies with a significant share in the automated insulin delivery (AID) […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Implants, Patient Monitoring, Technology Tagged With: Glucotrack, modularmedical, PharmaSens, Portal Diabetes, Sequel Med Tech, ViCentra

ViCentra names new CFO, adds board member

July 14, 2026 By Sean Whooley

ViCentra new CFO new board member Wells West

ViCentra announced today that it appointed Ian Wells as its new CFO and added Thomas A. West to its board of directors. Wells’ appointment went into effect on June 19, 2026, while West became an independent director on July 1, 2026. The Utrecht, the Netherlands-based automated insulin delivery system developer said the appointments lay the […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Personnel, Technology Tagged With: Personnel Moves, ViCentra

ViCentra Kaleido with G7, DBLG2 algorithm now available in Germany

July 10, 2026 By Sean Whooley

ViCentra Kaleido Diabeloop closed-loop automated insulin delivery system

Diabeloop announced today that its DBLG2 automated insulin delivery algorithm is now open for prescription with Dexcom G7 and ViCentra Kaleido. The companies now offer their integrated automated insulin delivery system in Germany, with availability to come in the Netherlands soon. Their updated system combines the company’s Kaleido patch pump with Diabeloop’s DBLG2 algorithm and the Dexcom G7 continuous glucose […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom, Diabeloop, ViCentra

ViCentra CEO explains how Kaleido can compete with ‘handbrake off,’ increased growth, scale

May 28, 2026 By Sean Whooley

ViCentra Kaleido users on a bench

Since ViCentra closed an $85 million funding round in September 2025, the milestones have continued to stack up. The Dutch automated insulin delivery system developer added a a $13 million extension to that Series D round in January. CEO Tom Arnold outlined the company’s plans for the cash infusion last year, including scaling manufacturing. Today, […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: kaleido, ViCentra

ViCentra triples manufacturing capacity ahead of Kaleido rollout through Phillips Medisize collab

May 28, 2026 By Sean Whooley

ViCentra Kaleido color stack

ViCentra announced today that it began commercial-scale production of its Kaleido insulin pump technology at Phillips Medisize. The Dutch automated insulin delivery system developer said it began production of consumables, including infusion sets and insulin cartridges, with the Molex company — a leading global medical technology contract development and manufacturing organization (CDMO). The collaboration more […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: kaleido, Phillips-Medisize, ViCentra

ViCentra launches smartphone-controlled Kaleido automated insulin patch pump system

May 12, 2026 By Sean Whooley

ViCentra Kaleido with DBLG 2 algorithm and Dexcom G7

ViCentra announced today that it launched its Kaleido smartphone-controlled hybrid closed-loop insulin delivery system in Europe. The new system combines the company’s Kaleido patch pump with Diabeloop’s DBLG2 algorithm and the Dexcom G7 continuous glucose monitor (CGM). It comes on the heels of Diabeloop’s CE mark for the next-generation algorithm paired with G7, announced yesterday. […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom, Diabeloop, ViCentra

Diabeloop gets CE mark for next-gen algorithm paired with Dexcom G7, ViCentra Kaleido

May 11, 2026 By Sean Whooley

Diabeloop DBLG2 with Dexcom G7

Diabeloop announced today that it received CE mark approval for its latest automated insulin delivery (AID) platform, DBLG2. CE mark approval comes not long after FDA approval in December 2025. The algorithm initially received CE mark last year but now has European approval for compatibility with next-generation devices. With clearance for DBLG2, integrated with the […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Regulatory/Compliance, Technology Tagged With: Dexcom, Diabeloop, ViCentra

ViCentra makes Kaleido automated insulin pump immediately available with no waiting period

April 16, 2026 By Sean Whooley

ViCentra Kaleido Blue worn on arm

ViCentra announced today that it made its Kaleido automated insulin pump immediately available, with no waiting period to get started. Kaleido, a miniature, patch-style insulin pump, is currently available in Germany, the Netherlands and France. Once a healthcare provider has prescribed Kaleido and the prescription has been approved, users can move very quickly to receive […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: ViCentra

ViCentra expects no immediate impact from Dexcom G6 discontinuation on Kaleido pump users

April 6, 2026 By Sean Whooley

ViCentra Kaleido users on a bench

ViCentra told customers that it expects no immediate impact from Dexcom’s planned discontinuation of the G6 CGM line. At the end of 2025, Dexcom had a posting on its website stating that it would soon cease manufacturing for its G6 continuous glucose monitor (CGM). After July 1, 2026, the company plans to no longer manufacture the […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Patient Monitoring, Technology Tagged With: Dexcom, ViCentra

ViCentra picks former Insulet leader as VP, global marketing

January 29, 2026 By Sean Whooley

ViCentra VP Global Marketing Reman McDonagh

Insulin patch pump maker ViCentra announced today that it appointed Reman McDonagh as its VP, global marketing. The Utrecth, the Netherlands-based company said McDonagh’s appointment further strengthens its leadership team as it scales commercial execution across Europe. It also bolsters the company amid preparations for its next-generation Kaleido system, including expected European and U.S. launches. McDonagh’s […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Personnel Tagged With: Personnel Moves, ViCentra

  • Page 1
  • Page 2
  • Page 3
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS